NCT04271618

Brief Summary

The aim of this study will be to evaluate the the effect of Thera Togs soft orthotic undergarment on modulation of the spinal geometry and mobility in sagittal plan in children with spastic diplegic cerebral palsy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 12, 2020

Completed
Same day until next milestone

Study Start

First participant enrolled

February 12, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 17, 2020

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2021

Completed
Last Updated

April 28, 2021

Status Verified

February 1, 2020

Enrollment Period

1.1 years

First QC Date

February 12, 2020

Last Update Submit

April 26, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change from baseline Thoracic kyphotic angle at 3 months

    Thoracic kyphotic angle will be calculated from the sagittal profile by Foremetric system.

    Baseline and 3 months post-intervention

  • Change from baseline lumber lordotic angle at 3 months

    Lumber lordotic angle will be calculated from the sagittal profile by Foremetric system.

    Baseline and 3 months post-intervention

Study Arms (2)

Traditional Treatment Arm

ACTIVE COMPARATOR

Participants in this group will receive conventional rehabilitation program for postural correction 2 hours/3 sessions' weekly/3 successive months.

Other: TheraTogs Orthotic Undergarment

TheraTogs Undergarment Arm

EXPERIMENTAL

Participants in this group will receive the same conventional rehabilitation program as in traditional group in addition to wearing of TheraTogs soft orthotic undergarment with strapping system.

Other: TheraTogs Orthotic Undergarment

Interventions

Strapping undergarment made from a lightweight, breathable fabric that is velcro sensitive. It consists of sleeveless vest (tank-Top), two shorts (Hipster) each with two thigh cuffs and limb cuffs

TheraTogs Undergarment ArmTraditional Treatment Arm

Eligibility Criteria

Age8 Years - 10 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Have a definite diagnosis of spastic diplegia obtained from medical files or personal physicians and supported by magnetic resonance images (MRIs).
  • Their weight should be less than 40 kg.
  • The degree of spasticity in the affected lower extremity will ranged between grades (1, 1+\&2) according to Modified Ashworth Scale.
  • The levels of gross motor function will be selected at level II according to Gross Motor Function Classification System.
  • The children will be included have the ability to stand alone for five minutes.
  • Children should be able to understand and follow instructions.
  • The degree of the spinal kyphosis ,for all participated children , in sagittal plane should be not more than 55° as Kyphosis above 55° is considered as fixed hyper-kyphosis while

You may not qualify if:

  • Children with GMFCS levels III, IV, and V or use any assistive mobility devices
  • Children suffering from allergic problems in their skin.
  • Children with visual, auditory or cognitive deficits.
  • Fixed and significant deformities of the lower limb and spine.
  • Children with surgical interference for the lower limb and spine within the previous 2 years.
  • Children with seizures.
  • Children with fixed hyper-kyphosis (kyphotic angle is more than 55°).
  • Children who used any medications (e.g., steroids) that affect growth or body composition.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maternity and Children Hospital

Mecca, Mecca Region, 149239, Saudi Arabia

Location

MeSH Terms

Conditions

Cerebral Palsy

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Shamekh M El-Shamy, Ph.D.

    Professor

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 12, 2020

First Posted

February 17, 2020

Study Start

February 12, 2020

Primary Completion

April 1, 2021

Study Completion

April 1, 2021

Last Updated

April 28, 2021

Record last verified: 2020-02

Data Sharing

IPD Sharing
Will not share

Locations